A Study of PRO95780 in Patients With Advanced Chondrosarcoma (APM4171g)

Summary

This is a multicenter, open-label, Phase II trial designed to evaluate the efficacy and safety of PRO95780 when given as a single agent in patients with advanced chondrosarcoma. Up to 90 patients with confirmed chondrosarcoma will be enrolled.

Timeline

Start

2007-05-31

Primary completion

2008-05-05

Completion

2008-05-05

Drugs

Indications